Detalles de la búsqueda
1.
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
N Engl J Med
; 382(23): 2187-2196, 2020 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32469183
2.
Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
JAMA Oncol
; 10(5): 594-602, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451492
3.
Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases.
Target Oncol
; 18(1): 95-103, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36472728
4.
Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.
Adv Ther
; 40(11): 4919-4927, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37713020
5.
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer.
Clin Genitourin Cancer
; 21(3): 383-392.e2, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062659
6.
Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer.
Cancers (Basel)
; 15(19)2023 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37835548
7.
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
Eur Urol Oncol
; 2023 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38143206
8.
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer.
Urol Oncol
; 41(11): 454.e9-454.e16, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734979
9.
A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent.
Clin Cancer Res
; 28(13): 2789-2795, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416959
10.
The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial.
Eur Urol
; 78(2): 184-192, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32273183
11.
Development and evaluation of the MiCheck test for aggressive prostate cancer.
Urol Oncol
; 38(8): 683.e11-683.e18, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32305266
12.
A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trial.
Urol Oncol
; 38(8): 683.e1-683.e10, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360170
13.
Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting.
Prostate Cancer Prostatic Dis
; 21(1): 78-84, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29158509
14.
Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker.
Oncotarget
; 9(32): 22359-22367, 2018 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29854284
15.
The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy.
Clin Genitourin Cancer
; 5(4): 271-7, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17553207
16.
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.
Cancer Prev Res (Phila)
; 10(5): 298-307, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28325826
17.
Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.
Eur J Cancer Prev
; 25(4): 312-20, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26313229
18.
A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.
Eur Urol
; 68(3): 464-70, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25454615
19.
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.
Cancer Prev Res (Phila)
; 5(4): 621-30, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22293631
20.
Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.
J Urol
; 168(2): 580-6, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12131314
Resultados
1 -
20
de 20
1
Próxima >
>>